| Atypical multidrug resistance: breast cancer resistance protein messenger RNA expression in mitoxantrone-selected cell lines DD Ross, W Yang, LV Abruzzo, WS Dalton, E Schneider, H Lage, ... Journal of the National Cancer Institute 91 (5), 429-433, 1999 | 508 | 1999 |
| Multidrug resistance-associated protein gene overexpression and reduced drug sensitivity of topoisomerase II in a human breast carcinoma MCF7 cell line selected for etoposide … E Schneider, JK Horton, CH Yang, M Nakagawa, KH Cowan Cancer research 54 (1), 152-158, 1994 | 343 | 1994 |
| Overexpression of wild-type breast cancer resistance protein mediates methotrexate resistance EL Volk, KM Farley, Y Wu, F Li, RW Robey, E Schneider Cancer research 62 (17), 5035-5040, 2002 | 336 | 2002 |
| DNA topoisomerases as anticancer drug targets E Schneider, YH Hsiang, LF Liu Advances in pharmacology 21, 149-183, 1990 | 307 | 1990 |
| Wild-type breast cancer resistance protein (BCRP/ABCG2) is a methotrexate polyglutamate transporter EL Volk, E Schneider Cancer research 63 (17), 5538-5543, 2003 | 293 | 2003 |
| The product of the ABC half-transporter gene ABCG2 (BCRP/MXR/ABCP) is expressed in the plasma membrane E Rocchi, A Khodjakov, EL Volk, CH Yang, T Litman, SE Bates, ... Biochemical and biophysical research communications 271 (1), 42-46, 2000 | 268 | 2000 |
| Increased expression of the multidrug resistance-associated protein gene in relapsed acute leukemia E Schneider, KH Cowan, H Bader, S Toomey, GN Schwartz, JE Karp, ... | 222 | 1995 |
| Reduced Intracellular Drug Accumulation in the Absence of P-Glycoprotein (mdr1) Overexpression in Mitoxantrone-resistant Human MCF-7 Breast Cancer Cells M Nakagawa, E Schneider, KH Dixon, J Horton, K Kelley, C Morrow, ... Cancer research 52 (22), 6175-6181, 1992 | 204 | 1992 |
| Increased mitochondrial cytochrome c levels and mitochondrial hyperpolarization precede camptothecin-induced apoptosis in Jurkat cells JA Sanchez-Alcazar, JG Ault, A Khodjakov, E Schneider Cell Death & Differentiation 7 (11), 1090-1100, 2000 | 202 | 2000 |
| Coordinated action of glutathione S-transferases (GSTs) and multidrug resistance protein 1 (MRP1) in antineoplastic drug detoxification: mechanism of GST A1-1-and MRP1 … CS Morrow, PK Smitherman, SK Diah, E Schneider, AJ Townsend Journal of Biological Chemistry 273 (32), 20114-20120, 1998 | 193 | 1998 |
| Mitomycin C induces apoptosis and caspase-8 and-9 processing through a caspase-3 and Fas-independent pathway F Pirnia, E Schneider, DC Betticher, MM Borner Cell Death & Differentiation 9 (9), 905-914, 2002 | 182 | 2002 |
| BCRP/MXR/ABCP expression in topotecan-resistant human breast carcinoma cells CH Yang, E Schneider, ML Kuo, EL Volk, E Rocchi, YC Chen Biochemical pharmacology 60 (6), 831-837, 2000 | 167 | 2000 |
| Paclitaxel chemotherapy after autologous stem-cell transplantation and engraftment of hematopoietic cells transduced with a retrovirus containing the multidrug resistance … KH Cowan, JA Moscow, H Huang, JA Zujewski, J O’Shaughnessy, ... Clinical Cancer Research 5 (7), 1619-1628, 1999 | 158 | 1999 |
| Notch1 regulates the expression of the multidrug resistance gene ABCC1/MRP1 in cultured cancer cells S Cho, M Lu, X He, PLR Ee, U Bhat, E Schneider, L Miele, WT Beck Proceedings of the National Academy of Sciences 108 (51), 20778-20783, 2011 | 156 | 2011 |
| Methotrexate cross-resistance in a mitoxantrone-selected multidrug-resistant MCF7 breast cancer cell line is attributable to enhanced energy-dependent drug efflux EL Volk, K Rohde, M Rhee, JJ McGuire, LA Doyle, DD Ross, E Schneider Cancer research 60 (13), 3514-3521, 2000 | 155 | 2000 |
| Drug-induced apoptosis is not necessarily dependent on macromolecular synthesis or proliferation in the p53-negative human prostate cancer cell line PC-3 MM Borner, CE Myers, O Sartor, Y Sei, T Toko, JB Trepel, E Schneider Cancer research 55 (10), 2122-2128, 1995 | 151 | 1995 |
| Topoisomerase II levels and drug sensitivity in adult acute myelogenous leukemia SH Kaufmann, JE Karp, RJ Jones, CB Miller, E Schneider, LA Zwelling, ... | 150 | 1994 |
| Early introductions and transmission of SARS-CoV-2 variant B. 1.1. 7 in the United States T Alpert, AF Brito, E Lasek-Nesselquist, J Rothman, AL Valesano, ... Cell 184 (10), 2595-2604. e13, 2021 | 135 | 2021 |
| Amplification of 4q21–q22 and the MXR gene in independently derived mitoxantrone‐resistant cell lines T Knutsen, VK Rao, T Ried, L Mickley, E Schneider, K Miyake, ... Genes, Chromosomes and Cancer 27 (1), 110-116, 2000 | 127 | 2000 |
| Cross-resistance to camptothecin analogues in a mitoxantrone-resistant human breast carcinoma cell line is not due to DNA topoisomerase I alterations CHJ Yang, JK Horton, KH Cowan, E Schneider Cancer research 55 (18), 4004-4009, 1995 | 125 | 1995 |
